Author Correction: JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders.

Autor: Ambrus-Aikelin G; Jecure Therapeutics, San Diego, CA, USA., Takeda K; Department of Pediatrics, National Jewish Health, Denver, CO, USA., Joetham A; Department of Pediatrics, National Jewish Health, Denver, CO, USA., Lazic M; Jecure Therapeutics, San Diego, CA, USA., Povero D; Jecure Therapeutics, San Diego, CA, USA. povero.davide@mayo.edu.; Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA. povero.davide@mayo.edu., Santini AM; Jecure Therapeutics, San Diego, CA, USA., Pranadinata R; Jecure Therapeutics, San Diego, CA, USA., Johnson CD; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA., McGeough MD; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA., Beasley FC; Jecure Therapeutics, San Diego, CA, USA., Stansfield R; Jecure Therapeutics, San Diego, CA, USA., McBride C; Jecure Therapeutics, San Diego, CA, USA., Trzoss L; Jecure Therapeutics, San Diego, CA, USA., Hoffman HM; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA., Feldstein AE; Department of Pediatrics, University of California San Diego, La Jolla, CA, USA., Stafford JA; Jecure Therapeutics, San Diego, CA, USA., Veal JM; Jecure Therapeutics, San Diego, CA, USA., Bain G; Jecure Therapeutics, San Diego, CA, USA., Gelfand EW; Department of Pediatrics, National Jewish Health, Denver, CO, USA.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2023 Nov 16; Vol. 13 (1), pp. 20081. Date of Electronic Publication: 2023 Nov 16.
DOI: 10.1038/s41598-023-47251-0
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje